Ellevest Inc’s Guardant Health GH Stock Holding History

Ellevest Inc’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5	Closed	–	–	1166
2019 Q4	$0	Hold	5	–	–	﹤0.01%	999
2019 Q3	$0	Sell	5 -8	-62%	-$705	﹤0.01%	542
2019 Q2	$1K	Buy	+13	New	+$993	﹤0.01%	366

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ellevest Inc's GH Position: Q1 2020 in Review

Ellevest Inc sold out of Guardant Health (GH) in Q1 2020, closing a stake of 5 shares.

Ellevest Inc first reported a position in GH in Q2 2019 and held it in 3 quarters. The position peaked at $1K in Q2 2019. 287 funds tracked by Wall St. Rank hold GH as of Q1 2020.

Ellevest Inc reported no remaining Guardant Health position as of Q1 2020 after selling out during the quarter.
Ellevest Inc sold 5 Guardant Health shares in Q1 2020.
Ellevest Inc first reported a position in Guardant Health in Q2 2019 and held it in 3 quarters.
Ellevest Inc's Guardant Health position peaked at $1K in Q2 2019.
287 funds tracked by Wall St. Rank held Guardant Health as of Q1 2020.

Based on Ellevest Inc's 13F filing for Q1 2020, filed 13 Apr 2020.